The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
The Nrf2-ARE signaling pathway: An update on its regulation and possible role in cancer prevention and treatment
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova-Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,141
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., & Motohashi, H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.016 · Cited by 1,395
The emerging role of the Nrf2–Keap1 signaling pathway in cancer
Jaramillo, M. C., & Zhang, D. D. (2013) · Genes & Development · doi:10.1101/gad.225680.113 · Cited by 1,297
The cytoprotective role of the Keap1–Nrf2 pathway
Baird, L., & Dinkova-Kostova, A. T. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0674-5 · Cited by 1,027
The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation
Bryan, H. K., Olayanju, A., Goldring, C. E., & Park, B. K. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.11.016 · Cited by 1,024
Lau, A., Wang, X.-J., Zhao, F., Villeneuve, N. F., Wu, T., Jiang, T., Sun, Z., White, E., & Zhang, D. D. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00248-10 · Cited by 849
The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
Lu, M., Ji, J., Jiang, Z., & You, Q. (2016) · Medicinal Research Reviews · doi:10.1002/med.21396 · Cited by 790
Small Molecule Modulators of Keap1‐ Nrf2‐ ARE Pathway as Potential Preventive and Therapeutic Agents
Magesh, S., Chen, Y., & Hu, L. (2012) · Medicinal Research Reviews · doi:10.1002/med.21257 · Cited by 760
Cullinan, S. B., & Diehl, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314219200 · Cited by 744
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
Ren, D., Villeneuve, N. F., Jiang, T., Wu, T., Lau, A., Toppin, H. A., & Zhang, D. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014275108 · Cited by 673
Chowdhry, S., Zhang, Y., McMahon, M., Sutherland, C., Cuadrado, A., & Hayes, J. D. (2013) · Oncogene · doi:10.1038/onc.2012.388 · Cited by 657
Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
Hayes, J. D., McMahon, M., Chowdhry, S., & Dinkova-Kostova, A. T. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3221 · Cited by 539
Jain, A. K., & Jaiswal, A. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611336200 · Cited by 483
The Nrf2 System as a Potential Target for the Development of Indirect Antioxidants
Jung, K.-A., & Kwak, M.-K. (2010) · Molecules · doi:10.3390/molecules15107266 · Cited by 474
The complexity of the Nrf2 pathway: beyond the antioxidant response
Huang, Y., Li, W., Su, Z.-Y., & Kong, A.-N. T. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.001 · Cited by 445
Chen, C.-Y., Jang, J.-H., Li, M.-H., & Surh, Y.-J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.237 · Cited by 428
Chen, C., Yu, R., Owuor, E. D., & Tony Kong, A. N. (2000) · Archives of Pharmacal Research · doi:10.1007/bf02975249 · Cited by 403
The Keap1–Nrf2 system in cancers: stress response and anabolic metabolism
Mitsuishi, Y., Motohashi, H., & Yamamoto, M. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00200 · Cited by 392
NRF2-regulation in brain health and disease: Implication of cerebral inflammation
Sandberg, M., Patil, J., D'Angelo, B., Weber, S. G., & Mallard, C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.004 · Cited by 390
Xu, C., Huang, M.-T., Shen, G., Yuan, X., Lin, W., Khor, T. O., Conney, A. H., & Kong, A.-N. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0300 · Cited by 380
Sangokoya, C., Telen, M. J., & Chi, J.-T. (2010) · Blood · doi:10.1182/blood-2009-04-214817 · Cited by 357
Tang, X., Wang, H., Fan, L., Wu, X., Xin, A., Ren, H., & Wang, X. J. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.008 · Cited by 325
Abed, D. A., Goldstein, M., Albanyan, H., Jin, H., & Hu, L. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.008 · Cited by 319
Molecular Basis of Electrophilic and Oxidative Defense: Promises and Perils of Nrf2
Ma, Q., & He, X. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.004333 · Cited by 317
Wang, X. J., Hayes, J. D., Henderson, C. J., & Wolf, C. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709483104 · Cited by 309
miR-200a Regulates Nrf2 Activation by Targeting Keap1 mRNA in Breast Cancer Cells
Eades, G., Yang, M., Yao, Y., Zhang, Y., & Zhou, Q. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.275495 · Cited by 305
Keum, Y.-S., Yu, S., Chang, P. P.-J., Yuan, X., Kim, J.-H., Xu, C., Han, J., Agarwal, A., & Kong, A.-N. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3513 · Cited by 303
The Nrf2/HO‐1 Axis in Cancer Cell Growth and Chemoresistance
Furfaro, A. L., Traverso, N., Domenicotti, C., Piras, S., Moretta, L., Marinari, U. M., Pronzato, M. A., & Nitti, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1958174 · Cited by 295
MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism
Yang, M., Yao, Y., Eades, G., Zhang, Y., & Zhou, Q. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1604-1 · Cited by 280
Farombi, E. O., Shrotriya, S., Na, H.-K., Kim, S.-H., & Surh, Y.-J. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.09.095 · Cited by 278
Habib, E., Linher-Melville, K., Lin, H.-X., & Singh, G. (2015) · Redox Biology · doi:10.1016/j.redox.2015.03.003 · Cited by 271
Chen, C., Pung, D., Leong, V., Hebbar, V., Shen, G., Nair, S., Li, W., & Tony Kong, A.-N. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.07.021 · Cited by 260
Hast, B. E., Goldfarb, D., Mulvaney, K. M., Hast, M. A., Siesser, P. F., Yan, F., Hayes, D. N., & Major, M. B. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4400 · Cited by 259
Epigenetic regulation of Keap1-Nrf2 signaling
Guo, Y., Yu, S., Zhang, C., & Kong, A.-N. T. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.013 · Cited by 258
Nrf2 affects the efficiency of mitochondrial fatty acid oxidation
Ludtmann, M. H. R., Angelova, P. R., Zhang, Y., Abramov, A. Y., & Dinkova-Kostova, A. T. (2014) · Biochemical Journal · doi:10.1042/bj20130863 · Cited by 240
Molecular and Chemical Regulation of the Keap1-Nrf2 Signaling Pathway
Keum, Y.-S., & Choi, B. (2014) · Molecules · doi:10.3390/molecules190710074 · Cited by 224
Nrf2: control of sensitivity to carcinogens
Slocum, S. L., & Kensler, T. W. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0675-4 · Cited by 219
Dietz, B. M., Kang, Y.-H., Liu, G., Eggler, A. L., Yao, P., Chadwick, L. R., Pauli, G. F., Farnsworth, N. R., Mesecar, A. D., van Breemen, R. B., et al. (2005) · Chemical Research in Toxicology · doi:10.1021/tx050058x · Cited by 207
Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein–protein interaction
Hu, L., Magesh, S., Chen, L., Wang, L., Lewis, T. A., Chen, Y., Khodier, C., Inoyama, D., Beamer, L. J., Emge, T. J., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.013 · Cited by 200
Narasimhan, M., Patel, D., Vedpathak, D., Rathinam, M., Henderson, G., & Mahimainathan, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051111 · Cited by 199
MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis
Singh, B., Ronghe, A. M., Chatterjee, A., Bhat, N. K., & Bhat, H. K. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt026 · Cited by 199
McNally, S., Harrison, E., Ross, J., Garden, O., & Wigmore, S. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.1.165 · Cited by 192
Yates, M. S., Kwak, M.-K., Egner, P. A., Groopman, J. D., Bodreddigari, S., Sutter, T. R., Baumgartner, K. J., Roebuck, B. D., Liby, K. T., Yore, M. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3823 · Cited by 191
Gao, A.-M., Ke, Z.-P., Shi, F., Sun, G.-C., & Chen, H. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.08.008 · Cited by 189
Garg, R., Gupta, S., & Maru, G. B. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn064 · Cited by 185
Pall, M. L., & Levine, S. A. (2015) · PubMed · Cited by 183
Truong Do, M., Gyun Kim, H., Ho Choi, J., & Gwang Jeong, H. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.010 · Cited by 172
The Keap1–Nrf2 Cell Defense Pathway – A Promising Therapeutic Target?
Copple, I. M. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-398339-8.00002-1 · Cited by 171
Harder, B., Jiang, T., Wu, T., Tao, S., de la Vega, M. R., Tian, W., Chapman, E., & Zhang, D. D. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150020 · Cited by 170
Gao, A.-M., Ke, Z.-P., Wang, J.-N., Yang, J.-Y., Chen, S.-Y., & Chen, H. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt108 · Cited by 168
Bai, X., Chen, Y., Hou, X., Huang, M., & Jin, J. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1197239 · Cited by 164
Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy
de Haan, J. B. (2011) · Diabetes · doi:10.2337/db11-1072 · Cited by 157
Krajka‐Kuźniak, V., Paluszczak, J., Szaefer, H., & Baer‐Dubowska, W. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513001645 · Cited by 144
Self-citationWang, X.-J., Sun, Z., Chen, W., Li, Y., Villeneuve, N. F., & Zhang, D. D. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.03.003 · Cited by 143
Su, Z., Zhang, C., Lee, J. H., Shu, L., Wu, T., Khor, T. O., Conney, A. H., Lu, Y.-P., & Kong, A. T. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0313-t · Cited by 143
Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer
Namani, A., Li, Y., Wang, X. J., & Tang, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.003 · Cited by 139
Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer
Muscarella, L. A., Parrella, P., D’Alessandro, V., la Torre, A., Barbano, R., Fontana, A., Tancredi, A., Guarnieri, V., Balsamo, T., Coco, M., et al. (2011) · Epigenetics · doi:10.4161/epi.6.6.15773 · Cited by 139
MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression
Kabaria, S., Choi, D. C., Chaudhuri, A., Jain, M. R., Li, H., & Junn, E. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.09.010 · Cited by 135
Lian, F., Smith, D. E., Ernst, H., Russell, R. M., & Wang, X. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm076 · Cited by 135
Zhai, X., Lin, M., Zhang, F., Hu, Y. W., Xu, X., Li, Y., Liu, K., Ma, X., Tian, X., & Yao, J. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200536 · Cited by 134
Regulatory Nexus of Synthesis and Degradation Deciphers Cellular Nrf2 Expression Levels
Suzuki, T., Shibata, T., Takaya, K., Shiraishi, K., Kohno, T., Kunitoh, H., Tsuta, K., Furuta, K., Goto, K., Hosoda, F., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00065-13 · Cited by 128
Truong, M., Kim, H. G., Khanal, T., Choi, J. H., Kim, D. H., Jeong, T. C., & Jeong, H. G. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.05.010 · Cited by 127
Shi, L., Wu, L. J., Chen, Z., Yang, J., Chen, X., Yu, F., Zheng, F., & Lin, X. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000374036 · Cited by 126
The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response
Hussong, M., Börno, S. T., Kerick, M., Wunderlich, A., Franz, A. M., Sültmann, H., Timmermann, B., Lehrach, H., Hirsch‐Kauffmann, M., & Schweiger, M. R. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.157 · Cited by 125
Diallyl sulfide induces heme oxygenase-1 through MAPK pathway
Gong, P., Hu, B., & Cederbaum, A. I. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.09.024 · Cited by 125
NRF2 Oxidative Stress Induced by Heavy Metals is Cell Type Dependent
Simmons, S. O., Fan, C., Yeoman, K., Wakefield, J., & Ramabhadran, R. (2011) · Current Chemical Genomics · doi:10.2174/1875397301105010001 · Cited by 122
de Oliveira, M. R., Ferreira, G. C., Schuck, P. F., & Bosco, S. M. D. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.11.003 · Cited by 116
Anti-inflammatory Effect of a Cell-Penetrating Peptide Targeting the Nrf2/Keap1 Interaction
Steel, R., Cowan, J., Payerne, E., O'Connell, M. A., & Searcey, M. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300041g · Cited by 113
Nitric oxide activation of Keap1/Nrf2 signaling in human colon carcinoma cells
Li, C.-Q., Kim, M. Y., Godoy, L. C., Thiantanawat, A., Trudel, L. J., & Wogan, G. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907539106 · Cited by 108
Cinnamoyl-based Nrf2-activators targeting human skin cell photo-oxidative stress
Wondrak, G. T., Cabello, C. M., Villeneuve, N. F., Zhang, S., Ley, S., Li, Y., Sun, Z., & Zhang, D. D. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.04.023 · Cited by 103
Stachurska, A., Cieśla, M., Kozakowska, M., et al. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200456 · Cited by 103
AberrantKeap1methylation in breast cancer and association with clinicopathological features
Barbano, R., Muscarella, L. A., Pasculli, B., Valori, V. M., Fontana, A., Coco, M., la Torre, A., Balsamo, T., Poeta, M. L., Marangi, G. F., et al. (2012) · Epigenetics · doi:10.4161/epi.23319 · Cited by 94
Epigenetic DNA Methylation of Antioxidative Stress Regulator NRF2 in Human Prostate Cancer
Khor, T. O., Fuentes, F., Shu, L., Paredes‐Gonzalez, X., Yang, Y., Liu, Y., Smiraglia, D. J., Yegnasubramanian, S., Nelson, W. G., & Kong, A. T. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0127 · Cited by 94
Cytoprotection “gone astray’’: Nrf2 and its role in cancer
Schäfer, H., Geismann, C., Arlt, A., & Sebens, S. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s36624 · Cited by 93
Kim, J.-H., Lee, K.-S., Lee, D.-K., Kim, J., Kwak, S.-N., Ha, K., Choe, J., Won, M., Cho, B. R., Jeoung, D., et al. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5856 · Cited by 92
Narasimhan, M., Riar, A. K., Rathinam, M. L., Vedpathak, D., Henderson, G. I., & Mahimainathan, L. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.05.020 · Cited by 91
Shi, L., Chen, Z., Wu, L., Zheng, J., Yang, J., Chen, X., Chen, Z.-Q., Cun-li, L., Chi, S.-Y., Zheng, J., et al. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.23.10439 · Cited by 91
You, A., Nam, C.-W., Wakabayashi, N., Yamamoto, M. P., Kensler, T. W., & Kwak, M.-K. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.12.034 · Cited by 88
Shen, T., Jiang, T., Long, M., Chen, J., Ren, D.-M., Wong, P. K., Chapman, E., Zhou, B., & Zhang, D. D. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6074 · Cited by 82
Peptide and small molecule inhibitors of the Keap1–Nrf2 protein–protein interaction
Wells, G. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150051 · Cited by 82
Kalayarasan, S., Narayanan, S., Sureshkumar, A., & Sudhandiran, G. (2008) · Journal of Applied Toxicology · doi:10.1002/jat.1355 · Cited by 80
Krajka‐Kuźniak, V., Paluszczak, J., Szaefer, H., & Baer‐Dubowska, W. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0401-4 · Cited by 80
Self-citationSulforaphane prevents doxorubicin-induced oxidative stress and cell death in rat H9c2 cells
Li, B., KIM, D. S., YADAV, R. K., Kim, H., & Chae, H. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2199 · Cited by 80
Bodduluru, L. N., Kasala, E. R., Barua, C. C., Karnam, K. C., Dahiya, V., & Ellutla, M. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.10.020 · Cited by 78
Nrf2: bane or blessing in cancer?
Xiang, M., Namani, A., Wu, S., & Wang, X. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1627-1 · Cited by 77
Kavitha, K., Thiyagarajan, P., Nandhini, J. R., Mishra, R., & Nagini, S. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.004 · Cited by 74
The Impact of miRNA-Based Molecular Diagnostics and Treatment of NRF2-Stabilized Tumors
Yamamoto, S., Inoue, J., Kawano, T., Kozaki, K., Omura, K., & Inazawa, J. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0246-t · Cited by 73
Becks, L., Prince, M., Burson, H. C., Christophe, C., Broadway, M., Itoh, K., Yamamoto, M. P., Mathis, J. M., Orchard, E. A., Shi, R., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-540 · Cited by 72
Comparison of citrus coumarins on carcinogen-detoxifying enzymes in Nrf2 knockout mice
Prince, M., Li, Y., Childers, A., Itoh, K., Yamamoto, M. P., & Kleiner, H. E. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.12.014 · Cited by 67
UHRF1 regulation of the Keap1–Nrf2 pathway in pancreatic cancer contributes to oncogenesis
AbuAlainin, W., Gana, T., Liloglou, T., Olayanju, A., Barrera, L. N., Ferguson, R., Campbell, F., Andrews, T., Goldring, C. E., Kitteringham, N. R., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4665 · Cited by 63
To, C., Ringelberg, C. S., Royce, D. B., Williams, C. R., Risingsong, R., Sporn, M. B., & Liby, K. T. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv061 · Cited by 63
miRNA Influences in NRF2 Pathway Interactions within Cancer Models
Ayers, D., Baron, B., & Hunter, T. (2015) · Journal of Nucleic Acids · doi:10.1155/2015/143636 · Cited by 62
Spirt, S. D., Eckers, A., Wehrend, C., Micoogullari, M., Sies, H., Stahl, W., & Steinbrenner, H. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.011 · Cited by 56
Ohnuma, T., Matsumoto, T., Itoi, A., Kawana, A., Nishiyama, T., Ogura, K., & Hiratsuka, A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.014 · Cited by 55
Liao, J. C., Lee, K. T., You, B., Lee, C.-L., Chang, W. T., Wu, Y., & Lee, H. (2015) · Food & Nutrition Research · doi:10.3402/fnr.v59.29884 · Cited by 54
Massrieh, W., Derjuga, A., & Blank, V. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.53 · Cited by 48
Yuan, J.-H., Li, Y., & Yang, X. (2008) · Molecular Medicine · doi:10.2119/2007-00050.yuan · Cited by 45
Guo, Q., Shen, Z., Yu, H., Lu, G., Yu, Y. Q., Liu, X., & Zheng, P. (2016) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2016.20.1.15 · Cited by 45
Kuo, P., Brown, D. A., Scofield, B. A., Yu, I.-C. I., Chang, F., Wang, P., & Yen, J.-H. J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.03.015 · Cited by 45
Liu, M., Hu, C., Xu, Q., Chen, L., Ma, K., Xu, N., & Zhu, H. (2015) · Bioscience Reports · doi:10.1042/bsr20150092 · Cited by 37
Krajka‐Kuźniak, V., Szaefer, H., Stefański, T., Sobiak, S., Cichocki, M., & Baer‐Dubowska, W. (2014) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-014-0209-1 · Cited by 26
Self-citationMBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer
Zhang, B., Xu, J., Li, C. W., Shi, S., Ji, S., Xu, W., Liu, J., Jin, K., Liang, D., Liang, C., et al. (2016) · Current Molecular Medicine · doi:10.2174/1566524016666160316154150 · Cited by 19
Moo-Puc, R. E., Caamal‐Fuentes, E., Peraza-Sánchez, S. R., Ślusarz, A., Jackson, G. A., Drenkhahn, S. K., & Lubahn, D. B. (2015) · BioMed Research International · doi:10.1155/2015/847457 · Cited by 12
Kaufmann, K. B., Al‐Rifai, N., Ulbrich, F., Schallner, N., Rücker, H., Enzinger, M., Petkes, H., Pitzl, S., Goebel, U., & Amslinger, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142932 · Cited by 9
Cited by
Nrf2-Keap1 signaling in oxidative and reductive stress
Bellezza, I., Giambanco, I., Minelli, A., & Donato, R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.02.010 · Cited by 2,053
An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation
Saha, S., Buttari, B., Panieri, E., Profumo, E., & Saso, L. (2020) · Molecules · doi:10.3390/molecules25225474 · Cited by 1,388
Role of Glutathione in Cancer: From Mechanisms to Therapies
Kennedy, L., Sandhu, J. K., Harper, M.-E., & Cuperlovic-Culf, M. (2020) · Biomolecules · doi:10.3390/biom10101429 · Cited by 880
Tu, W., Wang, H., Li, S., Liu, Q., & Sha, H. (2019) · Aging and disease · doi:10.14336/ad.2018.0513 · Cited by 707
Sivandzade, F., Prasad, S., Bhalerao, A., & Cucullo, L. (2019) · Redox Biology · doi:10.1016/j.redox.2018.11.017 · Cited by 639
Metadata
- Authors
- Krajka-Kuźniak, V., Paluszczak, J., & Baer-Dubowska, W.
- Venue
- Pharmacological Reports
- Published
- 2017-06
- Volume
- 69
- Issue
- 3
- Pages
- 393-402
- ISSN
- 1734-1140 (ISSN-L)
- OpenAlex
- W2562518681
- Cited by
- 288
- References
- 105
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.